NCT00088868
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +51 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT01553357
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- IRCCS - CROB Ethic Committee Rionero in Vulture, Pz, Italy
NCT00064311
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00080925
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +65 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Completed
Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma
NCT00589381
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
- Locations
-
- Childrens Hospital Los Angeles Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00116961
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
Completed
Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
NCT00135187
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Michigan Cancer Center Ann Arbor, Michigan, United States
NCT00029224
- Conditions
- Blood Protein Disorders, Breast Cancer, Breast Diseases, +31 more
- Locations
-
- Stockton Hematology Oncology Medical Group Stockton, California, United States
- Osceola Cancer Center Kissimmee, Florida, United States
- Nevada Cancer Center Las Vegas, Nevada, United States
- Hematology-Oncology Associates PC Albuquerque, New Mexico, United States
NCT00608907
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Hematology Institute - Davidoff Center - Rabin Medical Center Petah Tikva, Israel
- Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy
- Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland
- Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warsaw, Poland